Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multihance vs Vasovist for Renal MRA
NCT00415805Phase 3Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Dec 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gadobenate dimeglumine in renal artery stenosis (RAS) (2 arms), sponsored by Bracco Diagnostics Inc. Primary endpoints: Sensitivity compared to DSA and Specificity compared to DSA. Started Dec 2006; status: completed.
02
Drugs
gadobenate dimeglumine
03
Conditions
renal artery stenosis (RAS)
Beyond the preview
Go deeper on NCT00415805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415805.